CIM
CNMD icon

Contravisory Investment Management’s CONMED CNMD Stock Holding History

Contravisory Investment Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,551
Closed -$122K – 214
2015
Q3 		$122K Buy
+2,551
New +$140K 0.03% 86
2014
Q4 		– Sell
-4,987
Closed -$184K – 161
2014
Q3 		$184K Hold
4,987
– – 0.04% 81
2014
Q2 		$220K Buy
+4,987
New +$226K 0.04% 74

Other funds holding CNMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Contravisory Investment Management's CNMD Position: Q4 2015 in Review

Contravisory Investment Management sold out of CONMED (CNMD) in Q4 2015, closing a stake of 2,551 shares — an estimated $122K sold.

Contravisory Investment Management first reported a position in CNMD in Q2 2014 and held it in 3 quarters. The position peaked at $220K in Q2 2014. 153 funds tracked by Wall St. Rank hold CNMD as of Q4 2015.

  • Contravisory Investment Management reported no remaining CONMED position as of Q4 2015 after selling out during the quarter.
  • Contravisory Investment Management sold 2,551 CONMED shares in Q4 2015, an estimated $122K.
  • Contravisory Investment Management first reported a position in CONMED in Q2 2014 and held it in 3 quarters.
  • Contravisory Investment Management's CONMED position peaked at $220K in Q2 2014.
  • 153 funds tracked by Wall St. Rank held CONMED as of Q4 2015.

Based on Contravisory Investment Management's 13F filing for Q4 2015, filed 12 Jan 2016.